课题基金 / 基金详情

Identification and clinical application of novel antiapoptotic factor produced from ovarian cancer cells

Identification and clinical application of novel antiapoptotic factor produced from ovarian cancer cells
新型卵巢癌细胞抗凋亡因子的鉴定及临床应用
批准号:
18591843
负责人:
TANAKA Tetsuji
金额:
$2.45万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007

项目摘要

项目成果

TANAKA Tetsuji的其他基金

相似基金

相关文献

中文摘要
翻译
2006年至2007年,我校动物中心发生小鼠肝炎病毒污染事件。包括我们的小鼠在内的所有实验动物首先被杀死,然后对中心进行消毒。然而,消毒6个月后,动物中心再次发现病毒。我们改变了实验计划,尝试更多的体外实验。2007年底,重新启动动物实验,目前正在进行小鼠杂交瘤实验。2007年,第一位首席调查员退休。因此,出乎意料的是,第一个实验计划不能完全执行,现在我们一直在继续原计划。(1) m细胞源性抗凋亡物质(MAAS)的生化表征:从培养上清中部分纯化MAAS,免疫Bal b/c小鼠制备特异性抗体产生杂交瘤。然而,由于动物中心的污染事故,所有免疫小鼠都被杀死了。自动物中心重新开放以来,动物实验已经重新开始。该单克隆抗体的建立将为分离纯化MAAS分子和克隆其cDNA提供可能。(2) MAAS对抗凋亡现象的生物学表征:(1)我们在其他实验中研究了抗肿瘤药物诱导卵巢衰竭的分子机制。偶然的机会,这些实验发现了可能的抗凋亡机制类似于maas诱导的抗凋亡。(2)我们从M细胞中建立了几种抗cddp细胞系。两株抗cddp细胞株的MAAS活性均高于亲本细胞。这些数据表明,MAAS活性的增加可能是获得性CDDP抗性的一个可能机制。
英文摘要
The animal center of our university had been contaminated with mouse hepatitis virus from 2006 to 2007. All the experimental animals including our mice were killed at first, and then the center was disinfected. However, 6 months after the disinfection, virus was found out again in the animal center. We changed experimental plans to try more in vitro experiments. In the end of 2007, animal experiments were restarted and we are now performing mouse hybridoma experiments. In 2007, the first head investigator was retired. Therefore, unexpectedly the first experimental plans could not performed completely and now we have been continuing the original plans.(1) Biochemical characterization of M-cell derived antiapoptotic substances (MAAS): We partially purified MAAS from the culture supernatants and immunized Bal b/c mice to mace specific antibody-producing hybridoma. However, all the immunized mice were killed because of the contamination accident in the animal center. Since reopening of the animal center, animal experiments have been restarted. Establishment of the monoclonal antibody will make possible to isolate pure MAAS molecules and clone their cDNA.(2) Biological characterization of anti-apoptotic phenomena by MAAS: (1) We have been investigating molecular mechanisms of anticancer drug-induced ovarian failure in the other experiments. By chance, those experiments had found possible antiapoptotic mechanisms similar to MAAS-induced antiapoptosis. (2) We have established several CDDP-resistant cell lines from M cells. Two CDDP-resistant cell lines produced much higher MAAS activity than that the parent cells. These data indicate that increased MAAS activity can be a possible mechanism of an acquired CDDP resistance.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Irradiation reduces bleomycin sensitivity in cervical squamous cancer cells in vitro,
辐射降低体外宫颈鳞状癌细胞对博来霉素的敏感性,
DOI: --
发表时间: 2007
期刊: european Journal of Gynaecological Oncology 28(印刷中)
影响因子: --
作者: [Tanaka T, Yukawa K, et al.]
通讯作者: et al.
DOI: --
发表时间: 2006
期刊: Oncology Reports 15(4)
影响因子: --
作者: [Tanaka T, Bai T, et al.]
通讯作者: et al.
Radiation reduces carboplatin sensitivity and enhances nedaplatin sensitivity in cervical squamous carcinoma cells in vitro.
体外宫颈鳞状癌细胞中放射会降低卡铂敏感性并增强奈达铂敏感性。
DOI: --
发表时间: 2007
期刊: European Journal of Gynaecological Oncology 28(印刷中)
影响因子: --
作者: [Tanaka T, Yukawa K, et al.]
通讯作者: et al.
Effective chemoradiotherapeutic protocol with 5-fluorouracil for cervical squamous cell carcinoma in vitro.
5-氟尿嘧啶对宫颈鳞状细胞癌的体外有效放化疗方案。
DOI: --
发表时间: 2006
期刊: European Journal of Gynaecological Oncology 27(3)
影响因子: --
作者: [Tanaka T, Yukawa K, et al.]
通讯作者: et al.
Multidrug-resistance of cancer cells and their recovery by regulating expressions of DAP kinase-related molecules
  • 批准号:
    20591959
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.91万
  • 财政年份:
    2008
  • 负责人:
    TANAKA Tetsuji
  • 依托单位:
Molecular targeting therapy for anticancer drug-resistant cancer cells derived from uterus and ovary
  • 批准号:
    17591752
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.3万
  • 财政年份:
    2005
  • 负责人:
    TANAKA Tetsuji
  • 依托单位:
Basic study to establish molecular diagnosis and gene therapy for anticancer drug-resistant cancer cells
  • 批准号:
    13470353
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $3.52万
  • 财政年份:
    2001
  • 负责人:
    TANAKA Tetsuji
  • 依托单位:
Expression cloning of anticancer drug-sensitivity-regulatory molecules in gynecologic malignancy
  • 批准号:
    11671642
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.3万
  • 财政年份:
    1999
  • 负责人:
    TANAKA Tetsuji
  • 依托单位:
海外基金